No Data
Leading technology in overcoming challenges! Midea Beijing Wandong Medical Technology launches key national special project for the 14th Five-Year Plan!
Midea Medical participates in a national key project focusing on the challenges of cardiovascular imaging.
Entering the ranks of high-end medical care in the country! Beijing Wandong Medical Technology (600055.SH) is on the DSA list.
Beijing Wandong Medical Technology's DSA products have been selected for the national high-end medical equipment.
Beijing Wandong Medical Technology (600055.SH): The WDL AI high-speed central processing system and the unique chip equipped with the WDL algorithm are key achievements independently developed by Beijing Wandong Medical Technology.
On December 26, at the interactive platform, Beijing Wandong Medical Technology (600055.SH) stated that the WDL AI High-Speed Central Processing System and the unique chips equipped with the WDL algorithm are key achievements independently developed by the company. The research and development team conducted in-depth studies on algorithm optimization and hardware architecture design, while also actively collaborating with leading experts in Semiconductors and Medical Devices both domestically and internationally to ensure that the chip's performance and reliability meet the high demands of the medical imaging field.
Beijing Wandong Medical (600055.SH): The launched Twin Star AI 3.0T is equipped with the WDL 1024 AI wide-area deep learning platform.
On December 26, GELONGHUI reported that Beijing Wandong Medical Technology (600055.SH) stated on the interactive platform that the launched Gemini AI 3.0T, equipped with the WDL 1024 AI wide-area deep learning platform, leverages AI capabilities to create an efficient "1024" workflow, achieving one-button scanning, zero-second preparation, double lesion detection, and quadruple scanning speed; at the same time, it opens the era of dual perfusion quantitative MRI, obtaining dual quantitative perfusion imaging of both DCE and DSC with one scan. The company will continue to promote the performance of high-end MRI products and deeply layout in various levels of Institutions.
China Post Securities: The old-for-new policy has entered the implementation phase, and the medical devices sector is expected to enter a period of high performance growth.
It is expected that in December and the first quarter of 2025, various provinces will gradually implement the trade-in policy, relevant hospital tenders will be initiated, and equipment manufacturers are expected to see a large number of trade-in orders in the fourth quarter.
Wandong Medical Report for the Third Quarter of 2024
